Details for Patent: 6,495,541
✉ Email this page to a colleague
Summary for Patent: 6,495,541
Title: | Tricyclic inhibitors of poly(ADP-ribose) polymerases |
Abstract: | Compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapuetics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and nuerodegenerative disease. ##STR1## As cancer therapuetics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation. |
Inventor(s): | Webber; Stephen Evan (San Diego, CA), Canan-Koch; Stacie S. (La Jolla, CA), Tikhe; Jayashree (San Diego, CA), Thoresen; Lars Henrik (College Station, TX) |
Assignee: | Agouron Pharmaceuticals, Inc. (La Jolla, CA) |
Application Number: | 09/479,896 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 6,495,541
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,495,541
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 1538 | ⤷ Sign Up | |||
Austria | 261963 | ⤷ Sign Up | |||
Australia | 2408800 | ⤷ Sign Up | |||
Australia | 781711 | ⤷ Sign Up | |||
Bulgaria | 105811 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |